Clinical Trial – Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study

Phase II Study of Monosialotetrahexosylganglioside for Cerebral Radiation Necrosis

Description:

Condition:

Radiotherapy

Treatment:

GM1

Start Date:

January 2012

Sponsor:

Fudan University

For More Information:

https://clinicaltrials.gov/show/NCT01884987